Literature DB >> 20008215

Integrative therapies for children with hematological malignancies.

Kara M Kelly1.   

Abstract

Evidence for integrative therapies (IT) in children with hematological malignancies is slowly evolving. The ideal model of integrative pediatric oncology would offer IT modalities that are deemed safe and effective in conjunction with effective conventional medical treatments. Because of potential interactions, herbs and other dietary supplements should be used with caution, especially during active therapy. Health and wellness should be the emphasis, with IT therapies supporting health promotion and key disease prevention strategies for childhood cancer survivors. All uses, responses, and effects of IT therapies should be carefully documented. A desire to use IT therapies may be an effort to become an active participant in the healing process. Health care providers should encourage, not discourage, this partnership.

Entities:  

Mesh:

Year:  2009        PMID: 20008215     DOI: 10.1182/asheducation-2009.1.307

Source DB:  PubMed          Journal:  Hematology Am Soc Hematol Educ Program        ISSN: 1520-4383


  4 in total

Review 1.  Yoga in addition to standard care for patients with haematological malignancies.

Authors:  Steffen Felbel; Joerg J Meerpohl; Ina Monsef; Andreas Engert; Nicole Skoetz
Journal:  Cochrane Database Syst Rev       Date:  2014-06-12

Review 2.  Meditation for adults with haematological malignancies.

Authors:  Ines Salhofer; Andrea Will; Ina Monsef; Nicole Skoetz
Journal:  Cochrane Database Syst Rev       Date:  2016-02-03

Review 3.  Integrative Therapy Use for Management of Side Effects and Toxicities Experienced by Pediatric Oncology Patients.

Authors:  Shana S Jacobs
Journal:  Children (Basel)       Date:  2014-11-14

Review 4.  Evidence, safety and recommendations for when to use acupuncture for treating cancer related symptoms: a narrative review.

Authors:  Stephen Birch; Myeong Soo Lee; Terje Alraek; Tae-Hun Kim
Journal:  Integr Med Res       Date:  2019-05-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.